TY - JOUR
T1 - Use of hospital care among Dutch diabetes patients
AU - de Vries, Silvia A.G.
AU - Bak, J.C.G.
AU - Stangenberger, V.A.
AU - Wouters, Michel W. J. M.
AU - Nieuwdorp, M.
AU - Sas, Theo C. J.
AU - Verheugt, C.L.
N1 - Funding Information: We thank Prof. Dr H. R. Büller (Department of Vascular Medicine, Amsterdam University Medical Centres, Amsterdam, The Netherlands) for his valuable comments on the manuscript. Max Nieuwdorp is supported by a personal ZONMW-VICI grant 2020 (09150182010020). This study received no specific grant or funding. Funding Information: We thank Prof. Dr H. R. Büller (Department of Vascular Medicine, Amsterdam University Medical Centres, Amsterdam, The Netherlands) for his valuable comments on the manuscript. Max Nieuwdorp is supported by a personal ZONMW‐VICI grant 2020 (09150182010020). This study received no specific grant or funding. Publisher Copyright: © 2023 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd.
PY - 2023/8
Y1 - 2023/8
N2 - Aim: To provide insight into healthcare resource utilization and hospital expenditure of patients treated for diabetes in Dutch hospitals. Materials and methods: We conducted an observational cohort study of 193 840 patients aged ≥18 years and treated for diabetes mellitus in 65 Dutch hospitals in 2019 to 2020, using real-world reimbursement data. Consultations, hospitalizations, technology use, total hospital and diabetes care costs (encompassing all care for diabetes itself) were assessed during 1-year follow-up. In addition, expenditure was compared with that in the general Dutch population. Results: Total hospital costs for all patients with diabetes were €1 352 690 257 (1.35 billion) per year, and 15.9% (€214 963 703) was associated with treatment of diabetes. Mean yearly costs per patient were €6978, with diabetes care costs of €1109. Mean hospital costs of patients exceeded that of the Dutch population three- to sixfold. Total hospital costs increased with age, whereas diabetes expenditure decreased with age (18-40 years, €1575; >70 years, €932). Of all patients with diabetes, 51.3% (n = 99 457) received care related to cardiovascular complications. Micro- and macrovascular complications, or a combination, increased hospital costs (1.4-5.3 times higher). Conclusions: The hospital resource use of Dutch diabetes patients is high, with a large burden of cardiovascular complications. Resource use is rooted mainly in hospital care of diabetes-related complications, not in the treatment of diabetes. Early treatment and prevention of complications remain imperative to taper future healthcare expenditure on patients with diabetes.
AB - Aim: To provide insight into healthcare resource utilization and hospital expenditure of patients treated for diabetes in Dutch hospitals. Materials and methods: We conducted an observational cohort study of 193 840 patients aged ≥18 years and treated for diabetes mellitus in 65 Dutch hospitals in 2019 to 2020, using real-world reimbursement data. Consultations, hospitalizations, technology use, total hospital and diabetes care costs (encompassing all care for diabetes itself) were assessed during 1-year follow-up. In addition, expenditure was compared with that in the general Dutch population. Results: Total hospital costs for all patients with diabetes were €1 352 690 257 (1.35 billion) per year, and 15.9% (€214 963 703) was associated with treatment of diabetes. Mean yearly costs per patient were €6978, with diabetes care costs of €1109. Mean hospital costs of patients exceeded that of the Dutch population three- to sixfold. Total hospital costs increased with age, whereas diabetes expenditure decreased with age (18-40 years, €1575; >70 years, €932). Of all patients with diabetes, 51.3% (n = 99 457) received care related to cardiovascular complications. Micro- and macrovascular complications, or a combination, increased hospital costs (1.4-5.3 times higher). Conclusions: The hospital resource use of Dutch diabetes patients is high, with a large burden of cardiovascular complications. Resource use is rooted mainly in hospital care of diabetes-related complications, not in the treatment of diabetes. Early treatment and prevention of complications remain imperative to taper future healthcare expenditure on patients with diabetes.
KW - cardiovascular disease
KW - cohort study
KW - diabetes complications
KW - health economics
KW - observational study
KW - real-world evidence
UR - http://www.scopus.com/inward/record.url?scp=85158165310&partnerID=8YFLogxK
U2 - https://doi.org/10.1111/dom.15105
DO - https://doi.org/10.1111/dom.15105
M3 - Article
C2 - 37157933
SN - 1462-8902
VL - 25
SP - 2268
EP - 2278
JO - Diabetes, obesity & metabolism
JF - Diabetes, obesity & metabolism
IS - 8
ER -